Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Provention Bio Inc buy Chardan Capital

Provention Bio Inc
Start price
€22.41
13.03.23 / 50%
Target price
€23.30
13.03.24
Performance (%)
1.07%
End price
-
14.03.24
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital shows slight gains of 1.07%. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Provention Bio Inc - - - -
iShares Core DAX® -0.874% 5.325% 6.865% 65.211%
iShares Nasdaq 100 -0.381% 1.979% 25.696% 90.325%
iShares Nikkei 225® -1.676% 1.952% 41.443% 80.623%
iShares S&P 500 -0.655% 2.069% 21.405% 70.737%

Comments by Chardan_Capital for this prediction

In the thread Provention Bio Inc diskutieren
Prediction Buy
Perf. (%) 1.07%
Target price 23.295
Change
Ends at 13.03.24

Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat

Chardan Capital 
0
Report Share
13.03.23
In the thread Trading Provention Bio Inc
Prediction Buy
Perf. (%) 1.07%
Target price 23.295
Change
Ends at 13.03.24

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
14.03.24